Header-Bild für Robotic Summit 2025
Profilbild für Spinal Cord Injury Treatment of the Future

Spinal Cord Injury Treatment of the Future

Donnerstag, 20. November 2025 16:30 - 16:50 CET Plenum

ReferentIn: Gil Hakim

tba

RednerInnen

Profilbild für Gil Hakim

Gil Hakim ReferentIn

CEO

With over 20 years of experience in life sciences, specializing in early-stage innovation and market strategy. Previously with Urogen Pharma (NASDAQ: URGN), he holds a B.Sc. in Life Sciences from Ben-Gurion University.